These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17296370)
1. Association of testis derived transcript gene variants and prostate cancer risk. Liu X; Cicek MS; Plummer SJ; Jorgenson E; Casey G; Witte JS J Urol; 2007 Mar; 177(3):894-8. PubMed ID: 17296370 [TBL] [Abstract][Full Text] [Related]
2. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411 [TBL] [Abstract][Full Text] [Related]
3. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375 [TBL] [Abstract][Full Text] [Related]
4. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515 [TBL] [Abstract][Full Text] [Related]
5. EphB2 SNPs and sporadic prostate cancer risk in African American men. Robbins CM; Hooker S; Kittles RA; Carpten JD PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658 [TBL] [Abstract][Full Text] [Related]
6. Replication of prostate cancer risk loci in a Japanese case-control association study. Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753 [TBL] [Abstract][Full Text] [Related]
7. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723 [TBL] [Abstract][Full Text] [Related]
8. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779 [TBL] [Abstract][Full Text] [Related]
9. Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Beuten J; Gelfond JA; Martinez-Fierro ML; Weldon KS; Crandall AC; Rojas-Martinez A; Thompson IM; Leach RJ Carcinogenesis; 2009 Aug; 30(8):1372-9. PubMed ID: 19528667 [TBL] [Abstract][Full Text] [Related]
10. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Singal R; Das PM; Manoharan M; Reis IM; Schlesselman JJ Oncol Rep; 2005 Aug; 14(2):569-73. PubMed ID: 16012746 [TBL] [Abstract][Full Text] [Related]
12. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955 [TBL] [Abstract][Full Text] [Related]
13. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer risk associated loci in African Americans. Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807 [TBL] [Abstract][Full Text] [Related]
15. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410 [TBL] [Abstract][Full Text] [Related]
16. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315 [TBL] [Abstract][Full Text] [Related]
18. Cytokine genetic polymorphisms and prostate cancer aggressiveness. Zabaleta J; Su LJ; Lin HY; Sierra RA; Hall MC; Sartor AO; Clark PE; Hu JJ; Ochoa AC Carcinogenesis; 2009 Aug; 30(8):1358-62. PubMed ID: 19474090 [TBL] [Abstract][Full Text] [Related]
19. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019 [TBL] [Abstract][Full Text] [Related]
20. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Hooker S; Bonilla C; Akereyeni F; Ahaghotu C; Kittles RA Prostate Cancer Prostatic Dis; 2008; 11(4):349-56. PubMed ID: 18026184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]